Founded in 1999, Purgo Biologics develops oral-health biomaterials for soft-tissue and bone regeneration, including its porcine-derived THE Graft bone matrix. Its Seoul-based research and development center works with clinicians, governments, and educational institutions, while the company supplies regenerative solutions to dental professionals in more than 30 countries. Purgo says its production site is regularly inspected by international agencies, with controls covering materials through finished products.